Alan Rees. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Age FactorsCoronary Disease/mortalityHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHyperlipoproteinemia Type II/diagnosisHyperlipoproteinemia Type II/drug therapyPractice Guidelines as Topic
Substances: See more » Hydroxymethylglutaryl-CoA Reductase Inhibitors
Year: 2008 PMID: 18840878 DOI: 10.1093/eurheartj/ehn448
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983